EPFL
Three EPFL startups went public in 2021
TechTransfer
EPFL
Three EPFL startups – Sophia Genetics, Astrocast and Onward Medical – went public in 2021, the same number as in the previous three decades combined. This record-breaking year reflects the drive of our local entrepreneurs as well as the bullish stock-market environment and fertile startup ecosystem in our region.
Swiss lockdown especially stressful for women and students
Research
EPFL
Three EPFL studies on the effects of Switzerland’s first COVID-19 lockdown have just been published. The research was based on a survey of Swiss residents carried out during the confinement, and illustrate how the restrictions caused higher stress levels and changed the way people view housing.
Can oil and water mix?
Research
EPFL
Common experience tells us that oil and water do not mix. Yet, it turns out that they can mix when oil is dispersed as small droplets in water. This strange behavior has long vexed scientists because there is no explanation for it. A team of EPFL and ICTP scientists have studied this question using novel optical technology and discovered the mechanism by which these two neutral and immiscible compounds can in fact mix together and form emulsions. The answer lies in the electrical charge distribution at the interface.
A postdoc program to train sustainability-oriented leaders
Teaching
EPFL
EPFL’s newest postdoc fellowship program – EPFLeaders4impact – will fund innovative research projects that address the UN’s Sustainable Development Goals. Funded in part by the EU, the program is designed to encourage joint R&D among EPFL laboratories, businesses and non-profit organizations.
“The EU is hitting the limits in the US system it's modeled after”
Research
EPFL
Policymakers need to reconsider the European Union’s heavy promotion of cross-border mobility if they want to preserve cohesion among member states, according to a new book by three researchers drawing on urban sociology studies carried out at EPFL.
Rigidifying cancer cells for better immunotherapy
Research
EPFL
EPFL scientists have found that stiffening the membranes of cancer cells can lead to improved immunotherapy outcomes. Preclinical tests show that it can increase long-term survival rates to nearly 50%.
Page 69 of 99